It’s likely that securities firms are justifiably ambivalent about the execution and clearing reforms coming for over-the-counter (OTC) derivatives. Yet a recent survey conducted by consultancy Rule Financial and Calypso Technology provides evidence that firms are making changes despite doubts about the reforms and their ability to reduce systemic risk. Half of the survey respondents… Read More >>
Waiting for the Regulators
Waiting for US regulators to finalize their new rules is like trusting the New York subway system to live up to its official schedule of departures and arrivals. You can be certain that everything will be late and there will be little concern for the consequences. This was painfully clear when the regulators came to… Read More >>
Vanguard’s OTC Timetable
Eventually, the new Dodd-Frank regulations for OTC derivatives will be ready for prime time, compelling firms to face a timetable for implementing them. William Thum, principal and senior derivatives counsel for mutual fund giant Vanguard, thinks that firms should be allowed to ease into the brave new OTC world rather than endure a wrenching transition…. Read More >>